Sep 15, 2026 07:00AM
Sep 15, 2026 07:00AM
Aug 10, 2026 04:00PM
Aug 3, 2026 07:00AM
Aug 3, 2026 07:00AM
Jun 12, 2026 07:01AM
Jun 12, 2026 07:00AM Rocket Pharmaceuticals Announces Closing of Sale of Rare Pediatric Disease Priority Review Voucher for $180 Million
May 28, 2026 07:00AM
May 7, 2026 04:00PM
Apr 28, 2026 07:00AM
Apr 28, 2026 07:00AM
Feb 26, 2026 04:00PM
Feb 23, 2026 07:00AM
Jan 5, 2026 07:00AM Rocket Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Nov 25, 2025 07:00AM
Nov 6, 2025 04:00PM
Oct 14, 2025 07:00AM
Oct 14, 2025 07:00AM
Oct 10, 2025 04:00PM
Aug 28, 2025 07:00AM
Aug 20, 2025 07:00AM FDA lifts clinical hold on Rocket Pharmaceuticals' Danon disease trial
Aug 20, 2025 07:00AM
Aug 7, 2025 04:00PM
Jul 24, 2025 07:00AM
Jul 24, 2025 07:00AM
Jul 17, 2025 07:00AM
Jul 17, 2025 07:00AM
Jun 30, 2025 07:00AM Rocket Pharmaceuticals (RCKT) Announces FDA IND Clearance of RP-A701 for the Treatment of BAG3-associated Dilated Cardiomyopathy
Jun 30, 2025 07:00AM
May 27, 2025 07:01AM
May 27, 2025 07:00AM
May 15, 2025 03:15PM
May 15, 2025 03:15PM
May 9, 2025 04:30PM
May 8, 2025 04:01PM Rocket Pharmaceuticals Reports First Quarter 2025 Financial Results and Highlights Recent Progress
Apr 3, 2025 07:00AM
Feb 27, 2025 04:01PM
Jan 2, 2025 04:00PM
Nov 26, 2024 07:00AM
Nov 18, 2024 11:00AM
Nov 18, 2024 11:00AM
Nov 12, 2024 04:01PM Rocket Pharmaceuticals to Present Updated Data from the Phase 1 Clinical Trial of RP-A501 for Danon Disease at the American Heart Association’s 2024 Late-Breaking Science Sessions
Nov 8, 2024 07:00AM
Nov 7, 2024 04:01PM
Sep 17, 2024 07:03AM
Sep 17, 2024 07:00AM
Sep 10, 2024 07:03AM
Sep 10, 2024 07:00AM
Aug 27, 2024 07:00AM Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences
Aug 5, 2024 04:01PM

1,199,261 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All